Skip to content

Raltegravir approved for first-line use in European Union

Switches to second-line ART occurring faster where viral load testing available

HIV treatment may induce protective immunity in brain, monkey study finds

People with HIV have 21-year reduction in life expectancy in US

Delays in switching treatment: NRTI resistance can be slower to emerge than expected

Early treatment and interruption makes no difference to disease progression, study finds

d4T dose reduction does not result in poorer treatment outcomes in South African patients

Clinical officers and nurses make similar decisions to physicians on starting antiretroviral therapy in rural Uganda

India rejects patents on two HIV drugs